HSCS, HSCSW · CIK 0001468492 · operating
HeartSciences Inc. is a medical technology company that develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions for cardiac assessment. The company applies machine learning algorithms to ECG data to detect cardiac dysfunction, including impaired relaxation and age-related conditions. Its primary product, the MyoVista wavECG device, is a resting 12-lead electrocardiograph that combines diagnostic information on cardiac function with conventional ECG data in a single test. The company also operates MyoVista Insights, a cloud-based platform designed to host AI-ECG algorithms independent of specific ECG hardware manufacturers.
The company was incorporated in Texas in 2007 under the name Heart Test Laboratories, Inc., and rebranded to HeartSciences Inc. in October 2024. It maintains its headquarters in Southlake, Texas, and operates with 15 full-time employees. The company is listed on Nasdaq, though it is classified under the SIC category for orthopedic, prosthetic, and surgical appliances and supplies.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-9.34 | $-9.34 | +50.8% | |
| 2024 | $-19.00 | $-19.00 | -2275.0% | |
| 2023 | $-0.80 | $-0.80 | — |